Recommended Topic Related To:

Xifaxan

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Xifaxan

Overdosage
Contraindications

OVERDOSE

No specific information is available on the treatment of overdosage with XIFAXAN. In clinical studies at doses higher than the recommended dose (> 600 mg/day for travelers' diarrhea or > 1100 mg/day for hepatic encephalopathy), adverse reactions were similar in subjects who received doses higher than the recommended dose and placebo. In the case of overdosage, discontinue XIFAXAN, treat symptomatically, and institute supportive measures as required.

CONTRAINDICATIONS

Hypersensitivity

XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin  antimicrobial agents, or any of the components in XIFAXAN. Hypersensitivity reactions have included  exfoliative dermatitis, angioneurotic edema, and anaphylaxis [see ADVERSE REACTIONS].

Last reviewed on RxList: 3/28/2014
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications
A A A

Xifaxan - User Reviews

Xifaxan User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Xifaxan sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD